Profusa (PFSA) Non-Current Debt (2023 - 2025)

Profusa's (PFSA) quarterly Non-Current Debt came in at $400000.0 in Q4 2025, down 52.94% year-on-year from $850000.0 in Q4 2024, and down 54.44% quarter-over-quarter from $878000.0 in Q3 2025.

Profusa (PFSA) Non-Current Debt (2023 - 2025) Analysis & Trends

Profusa's Non-Current Debt history runs 3 years deep, the most recent figure standing at $400000.0 for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 52.94% year-over-year to $400000.0 in Q4 2025; TTM through Dec 2025 was $400000.0, a 52.94% decrease from a year earlier, with the FY2025 full-year figure at $400000.0, down 52.94% from the prior year.
  • Non-Current Debt eased to $400000.0 in Q4 2025 per PFSA's latest filing, from $878000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $2.5 million in Q2 2025 and bottomed at $400000.0 in Q4 2025.
  • The 3-year median for Non-Current Debt is $1.8 million (2024), against an average of $1.6 million.
  • Biggest YoY gain for Non-Current Debt was 38.36% in 2025; the steepest drop was 59.31% in 2025.
  • Year by year, Non-Current Debt stood at $1.7 million in 2023, then plunged by 50.41% to $850000.0 in 2024, then slumped by 52.94% to $400000.0 in 2025.
  • Per Business Quant, the three latest PFSA Non-Current Debt figures stand at $400000.0 (Q4 2025), $878000.0 (Q3 2025), and $2.5 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 29.64 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 14.22 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 598.50 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.18 Bn
10 Profusa 23,566.40 -351,433.60 - -

Historic Data

Download Data
DateValue
Dec 31, 2025 400,000.00
Sep 30, 2025 878,000.00
Jun 30, 2025 2.54 Mn
Mar 31, 2025 2.39 Mn
Dec 31, 2024 850,000.00
Sep 30, 2024 2.16 Mn
Jun 30, 2024 1.84 Mn
Mar 31, 2024 1.77 Mn
Dec 31, 2023 1.71 Mn